Xiamen Fanchuang Cultural Industry Co., Ltd. – Trademark Portfolio

Entity Type: 99

Xiamen Fanchuang Cultural Industry Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include FEMOVAZ. The owner is based in Xiamen, Fujian.

3F-A190, Zone C, Innovation Building

Software Park, Torch High-tech Zone

Xiamen, Fujian 361000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

FEMOVAZ
FEMOVAZ
Registered 2023

Trademark Classifications

Xiamen Fanchuang Cultural Industry Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Xiamen Fanchuang Cultural Industry Co., Ltd. have?

Xiamen Fanchuang Cultural Industry Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Xiamen Fanchuang Cultural Industry Co., Ltd. file in?

Xiamen Fanchuang Cultural Industry Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Xiamen Fanchuang Cultural Industry Co., Ltd.'s most well-known trademarks?

Xiamen Fanchuang Cultural Industry Co., Ltd.'s registered trademark portfolio includes well-known marks such as FEMOVAZ. These are among 1 currently registered trademark in the portfolio.

What is Xiamen Fanchuang Cultural Industry Co., Ltd.'s trademark registration success rate?

Xiamen Fanchuang Cultural Industry Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.